[5/25/2022] FDA is alerting customers of North American Custom Laboratories LLC, doing business as FarmaKeio Superior Custom Compounding’s voluntary recall, initiated on April 5, 2022, of […]

Summary Company Announcement Date: March 30, 2026 FDA Publish Date: April 01, 2026 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Device & Drug […]

English Como apoyo a la seguridad pública, y debido a que algunos de estos productos aún pueden estar disponibles en el mercado, la FDA ha emitido […]

en Español [7/3/2023] Since April 20, 2022, FDA learned that more than 30 additional consumers have experienced a serious health effect after using unapproved over-the-counter products with […]

[4/26/2022] FDA is alerting patients, health care professionals, veterinarians, and animal owners/caretakers about a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy, of […]

On April 29, 2022, the U.S. Food and Drug Administration approved a modification to the Bosentan Risk Evaluation and Mitigation Strategy (REMS) program. Beginning June 27, […]

[11-8-2022] Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to […]

Update [8/25/2023] FDA is reminding the public that these recalled products should not be used, including off-label use in animals. FDA does not have direct knowledge […]

[5/1/2023] FDA is warning consumers to not purchase or use Nose Slap and Soul Slap products, which are unapproved drugs marketed to promote alertness and boost […]